logo-loader
FinanceBanks
Barclays

Barclays reportedly plans to cut bonuses for investment bankers amid activist investor pressure

The bank is also said to be planning to crack down on promotions for its bankers

Barclays
Activist investor Edward Bramson wants a seat on Barclays' board

Barclays PLC (LON:BARC) is understood to be planning to cut investment bankers’ bonuses amid pressure from an activist investor to scale back its investment division.

According to the Financial Times, Barclays wants to slash costs at its underperforming investment bank through pay cuts for bankers.

READ: Barclays activist investor Edward Bramson repeats call to join board

Annual bonuses are set to be more closely tied to performance, meaning accrual in the first quarter is expected to be down by double digits compared with last year, the newspaper said.

The bank is also said to be planning to crack down on promotions for its bankers. Last year, 85 bankers were promoted in Barclays International, compared to 74 in 2017.

The news comes as activist investor Edward Bramson, whose vehicle Sherborne Investors owns about 5.5% of Barclays, piles pressure on the bank to improve shareholder returns by shrinking the investment unit.

Bramson has called on shareholders to back his campaign to be elected as a non-executive director on the bank’s board at the annual general meeting on May 2.

However, leading shareholder advisory group, Glass Lewis, has told investors to oppose his bid for a seat on the board.

Merian Global Investors’ Richard Buxton, a leading investor in Barclays, said it would vote against Bramson’s proposal.

In afternoon trading, shares in Barclays - which reports its first-quarter results on Thursday - were 2.2% lower at 165.76p.

 -- Adds share price --

Quick facts: Barclays

Price: £1.52

Market: LSE
Market Cap: £26.14 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Alchemist sees big market in China for medical cannabis sales

Alchemist (CSE: AMS) CEO Paul Mann and Vice President of Business Development, Asia Pacific Johnson Lee joined Steve Darling from Proactive Vancouver to discuss Alchemist looking for opportunities for cannabis in the emerging cannabis market.  Mann and Lee talk about what the industry...

1 day, 18 hours ago

2 min read